Correlation Between NYSE Composite and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Design Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Design Therapeutics.
Diversification Opportunities for NYSE Composite and Design Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between NYSE and Design is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Design Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Design Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.14 times more return on investment than Design Therapeutics. However, NYSE Composite is 7.33 times less risky than Design Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Design Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 1,960,737 in NYSE Composite on November 18, 2024 and sell it today you would earn a total of 52,312 from holding NYSE Composite or generate 2.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Design Therapeutics
Performance |
Timeline |
NYSE Composite and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Design Therapeutics
Pair trading matchups for Design Therapeutics
Pair Trading with NYSE Composite and Design Therapeutics
The main advantage of trading using opposite NYSE Composite and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.NYSE Composite vs. Zhihu Inc ADR | NYSE Composite vs. Allied Gaming Entertainment | NYSE Composite vs. Asure Software | NYSE Composite vs. SohuCom |
Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |